Colorectal cancer is the second most common cancer among Malaysians, and is diagnosed at a relatively late stage compared to other developed Asian countries. Therefore, there is tremendous potential for the development of new biomarker discoveries and alternative therapies in the diagnosis and treatment of colorectal cancer. Dr Oon Chern Ein, a researcher in medical oncology from the Institute for Research in Molecular Medicine, Universiti Sains Malaysia, joins us to discuss the research by her team to develop a new anti-cancer agent for colorectal cancer.